Compass Therapeutics (CMPX) Depreciation and Depletion (2020 - 2026)
Compass Therapeutics (CMPX) reported Depreciation and Depletion of $15000.0 for Q1 2026, down 89.29% on a YoY basis from $140000.0 in Q1 2025, and down 85.0% sequentially from $100000.0 in Q3 2025.
Compass Therapeutics (CMPX) Depreciation and Depletion (2020 - 2026) Analysis & Trends
Compass Therapeutics (CMPX) has 7 years of Depreciation and Depletion data on file, last reported at $15000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation and Depletion fell 89.29% year-over-year to $15000.0; the trailing twelve-month figure through Mar 2026 stood at $175000.0 (down 67.59% YoY), and the FY2025 full-year result was $300000.0, down 50.0% from the prior year.
- Depreciation and Depletion slipped to $15000.0 in Q1 2026, from $100000.0 in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $200000.0 in Q1 2022 to a low of $15000.0 in Q1 2026.
- A 5-year average of $150937.5 and a median of $200000.0 in 2022 frame the typical range for Depreciation and Depletion.
- Across the five-year window, Depreciation and Depletion surged 100.0% in 2022 and sank 89.29% in 2026, its largest moves.
- Tracing CMPX's Depreciation and Depletion over 5 years: stood at $200000.0 in 2022, then changed by 0.0% to $200000.0 in 2023, then tumbled by 50.0% to $100000.0 in 2024, then changed by 0.0% to $100000.0 in 2025, then sank by 85.0% to $15000.0 in 2026.
- Business Quant data shows CMPX's Depreciation and Depletion at $15000.0 in Q1 2026, $100000.0 in Q3 2025, and $60000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 39.39 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Compass Therapeutics | 395.17 Mn | 200.48 Mn | - | 15,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15,000.00 |
| Mar 31, 2026 | 15,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 60,000.00 |
| Jun 30, 2025 | 60,000.00 |
| Mar 31, 2025 | 140,000.00 |
| Mar 31, 2025 | 140,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Sep 30, 2024 | 200,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 200,000.00 |
| Mar 31, 2024 | 200,000.00 |
| Dec 31, 2023 | 200,000.00 |
| Dec 31, 2023 | 200,000.00 |
| Sep 30, 2023 | 100,000.00 |
| Sep 30, 2023 | 100,000.00 |